Connected Wearable Patches Market by Product Type (Clinical Use, Non-Clinical Use); by Application (Monitoring, Detection & Diagnosis, Managing & Treatment, Health, Wellness & Prevention, Clinical Trials); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018-2026’

Report ID :AMI-64 | Category : Healthcare And IT | Published Date :June, 2018 | Pages : 175 | Format :PDF
Buy Now!

Industry Trends

Connected wearable patches include tags, tattoos, or small devices that are affixed to the skin and worn for a limited period of time, ranging from an hour to several weeks. The patches also have an element of wireless connectivity, and have a medical, health, or wellness purpose that can range from monitoring physiological data to delivering medication. The wearable technology devices are in high demand in the healthcare industry. Several connected wearable products are existing in various forms for many years. The development in wearable patches took place about a decade ago with the arrival of new sensors and low power radio chips. The market for connected wearable patches holds high demand, with the potential to improve the health of patients and contribute to lower healthcare costs. The market is however in the early stages of development and commercial availability. Advancements in the healthcare sector and growing health awareness worldwide is the primary factor driving the connected wearable patches market. The need to monitor health and fitness using wearable patches has also accentuated demand for the connected wearable patches. Growth in technological and medical capabilities is one of the major factor driving the growth of connected wearable patches market.

Connected Wearable Patches Market, By Region, 2018 – 2026, (USD Million)

Connected Wearable Patches Market

In terms of revenue, the global connected wearable patches market was US$ 166820 Mn in 2017 and is estimated to be US$ 412470 Mn by 2022.

Connected Wearable Patches, by Application

Connected wearable patches are widely used in monitoring a patient’s conditions and treating them on time. They are also used in diagnosing any abnormalities in body conditions. For instance, people with diabetes prick their fingers multiple times a day to check their blood glucose levels, and dose themselves timely with injections of insulin. Monitoring is crucial, as rises in sugar levels in the blood can over time increase a diabetic patient’s risks of developing long-term complications from the disease. When a diabetic person puts the patch on, the device captures sweat from the person’s skin. Sensors within the patch pick up on the sweat's pH and note the temperature change that occurs. The patch then sends a signal alerting high glucose level to inform both, the patient as well as the doctor. Once a high level is detected, heaters in the patch start to dissolve a layer of coating, exposing micro needles that release a drug called Metformin, which help to regulate and reduce high blood sugar levels. This is how a patient’s health is monitored by using skin wearable patches. Such patches are also used in monitoring and treating other body conditions such as obesity, heart attack and increased blood pressure. In 2018, scientists from the Nanyang Technological University developed a micro-needle patch that delivers fat-burning drugs into the body. The researchers hope that their wearable patch could be used to address worldwide obesity problems without the need for surgical operations.

Connected Wearable Patches Market, by Region

North America is leading in connected wearable patches market, due to the technological advancements and high investments made by the companies in the region. As per the import data of United States, the shipment of wearable devices in the first quarter of 2015 in the United States reached US$11.4 million units. There was an increase of 200% as compared to previous years. Businesses are developing wearable patches that aim to make living with certain illnesses and conditions more manageable. For example, the ADAM (asthma detection and monitoring) wearable patch detects symptoms and, via an app connection, monitors inhaler use and provides warning of impending asthma attacks by sending important data to a patient’s doctor. North America based technology companies such as Intel and Apple are investing heavily in wearable patches. Also, non-tech companies such as Nike, Proteus Digital Health and others are investing heavily in connected wearable patches market.

Competitive Landscape

The report provides both, qualitative and quantitative research of the market, as well as strategic insights along with developments that are being adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisition (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their research institutes, competitors, product type, application and specification, pricing, and gross margin.

Connected wearable patches market participants include TempTraq, Qualcomm Inc., Abbott Laboratories, Nemaura Medical Inc., G-Tech Inc., Proteus Digital Health, Inc., Chrono Therapeutics, Blue Spark Technologies, KENZEN, Gentag Inc., Preventice Solutions, Vital Connect, Vancive Medical, Sensium Healthcare, Medtronic, NeuroMetrix, Qardio, iRhythm amongst others.

Connected Wearable Patches Market Background

Connected Wearable Patches Market

1.    Introduction

1.1.   Market Scope

1.2.   Market Segmentation

1.3.   Methodology

1.4.   Assumptions

2.    Connected Wearable Patches Market Snapshot

3.    Executive Summary: Connected Wearable Patches Market

4.    Qualitative Analysis: Connected Wearable Patches Market

4.1.   Introduction

4.1.1.   Product Definition

4.1.2.   Industry Development

4.2.   Market Dynamics

4.2.1.   Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.3.   Trends in Market

5.    Global Connected Wearable Patches Market Analysis and Forecasts, 2018 – 2026

5.1.   Overview

5.1.1.   Global Market Revenue (US$ Mn) and Forecasts

5.2.   Global Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

5.2.1.   Clinical Use

5.2.1.1.    Definition

5.2.1.2.    Market Penetration

5.2.1.3.    Market Revenue Expected to Increase by 2026

5.2.1.4.    Compound Annual Growth Rate (CAGR)

5.2.2.   Non-Clinical Use

5.2.2.1.    Definition

5.2.2.2.    Market Penetration

5.2.2.3.    Market Revenue Expected to Increase by 2026

5.2.2.4.    Compound Annual Growth Rate (CAGR)

5.3.   Key Segment for Channeling Investments

5.3.1.   By Product Type

6.    Global Connected Wearable Patches Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.2.   Global Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Application

6.2.1.   Monitoring, Detection and Diagnosis

6.2.1.1.    Definition

6.2.1.2.    Market Penetration

6.2.1.3.    Market Revenue Expected to Increase by 2026

6.2.1.4.    Compound Annual Growth Rate (CAGR)

6.2.2.   Managing and Treatment

6.2.2.1.    Definition

6.2.2.2.    Market Penetration

6.2.2.3.    Market Revenue Expected to Increase by 2026

6.2.2.4.    Compound Annual Growth Rate (CAGR)

6.2.3.   Health, Wellness and Prevention

6.2.3.1.    Definition

6.2.3.2.    Market Penetration

6.2.3.3.    Market Revenue Expected to Increase by 2026

6.2.3.4.    Compound Annual Growth Rate (CAGR)

6.2.4.   Clinical Trials

6.2.4.1.    Definition

6.2.4.2.    Market Penetration

6.2.4.3.    Market Revenue Expected to Increase by 2026

6.2.4.4.    Compound Annual Growth Rate (CAGR)

6.3.   Key Segment for Channeling Investments

6.3.1.   By Application

7.    North America Connected Wearable Patches Market Analysis and Forecasts, 2018 – 2026

7.1.   Overview

7.1.1.   North America Market Revenue (US$ Mn)

7.2.   North America Market Revenue (US$ Mn) and Forecasts, By Product Type

7.2.1.   Clinical Use

7.2.2.   Non-Clinical Use

7.3.   North America Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Application

7.3.1.   Monitoring, Detection and Diagnosis

7.3.2.   Managing and Treatment

7.3.3.   Health, Wellness and Prevention

7.3.4.   Clinical Trials

7.4.   North America Market Revenue (US$ Mn) and Forecasts, By Country

7.4.1.   U.S.

7.4.1.1.    U.S. Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

7.4.1.1.1.    Clinical Use

7.4.1.1.2.    Non-Clinical Use

7.4.1.2.    U.S. Market Revenue (US$ Mn) and Forecasts, By Application

7.4.1.2.1.    Monitoring, Detection and Diagnosis

7.4.1.2.2.    Managing and Treatment

7.4.1.2.3.    Health, Wellness and Prevention

7.4.1.2.4.    Clinical Trials

7.4.2.   Rest of North America

7.4.2.1.    Rest of North America Market Revenue (US$ Mn) and Forecasts, By Product Type

7.4.2.1.1.    Clinical Use

7.4.2.1.2.    Non-Clinical Use

7.4.2.2.    Rest of North America Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Application

7.4.2.2.1.    Monitoring, Detection and Diagnosis

7.4.2.2.2.    Managing and Treatment

7.4.2.2.3.    Health, Wellness and Prevention

7.4.2.2.4.    Clinical Trials

7.5.   Key Segment for Channeling Investments

7.5.1.   By Country

7.5.2.   By Product Type

7.5.3.   By Application

8.    Europe Connected Wearable Patches Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.1.1.   Europe Market Revenue (US$ Mn)

8.2.   Europe Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

8.2.1.   Clinical Use

8.2.2.   Non-Clinical Use

8.3.   Europe Market Revenue (US$ Mn) and Forecasts, By Application

8.3.1.   Monitoring, Detection and Diagnosis

8.3.2.   Managing and Treatment

8.3.3.   Health, Wellness and Prevention

8.3.4.   Clinical Trials

8.4.   Europe Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Country

8.4.1.   France

8.4.1.1.    France Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

8.4.1.1.1.    Clinical Use

8.4.1.1.2.    Non-Clinical Use

8.4.1.2.    France Market Revenue (US$ Mn) and Forecasts, By Application

8.4.1.2.1.    Monitoring, Detection and Diagnosis

8.4.1.2.2.    Managing and Treatment

8.4.1.2.3.    Health, Wellness and Prevention

8.4.1.2.4.    Clinical Trials

8.4.2.   The UK

8.4.2.1.    The UK Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

8.4.2.1.1.    Clinical Use

8.4.2.1.2.    Non-Clinical Use

8.4.2.2.    The UK Market Revenue (US$ Mn) and Forecasts, By Application

8.4.2.2.1.    Monitoring, Detection and Diagnosis

8.4.2.2.2.    Managing and Treatment

8.4.2.2.3.    Health, Wellness and Prevention

8.4.2.2.4.    Clinical Trials

8.4.3.   Spain

8.4.3.1.    Spain Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

8.4.3.1.1.    Clinical Use

8.4.3.1.2.    Non-Clinical Use

8.4.3.2.    Spain Market Revenue (US$ Mn) and Forecasts, By Application

8.4.3.2.1.    Monitoring, Detection and Diagnosis

8.4.3.2.2.    Managing and Treatment

8.4.3.2.3.    Health, Wellness and Prevention

8.4.3.2.4.    Clinical Trials

8.4.4.   Germany

8.4.4.1.    Germany Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

8.4.4.1.1.    Clinical Use

8.4.4.1.2.    Non-Clinical Use

8.4.4.2.    Germany Market Revenue (US$ Mn) and Forecasts, By Application

8.4.4.2.1.    Monitoring, Detection and Diagnosis

8.4.4.2.2.    Managing and Treatment

8.4.4.2.3.    Health, Wellness and Prevention

8.4.4.2.4.    Clinical Trials

8.4.5.   Italy

8.4.5.1.    Italy Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

8.4.5.1.1.    Clinical Use

8.4.5.1.2.    Non-Clinical Use

8.4.5.2.    Italy Market Revenue (US$ Mn) and Forecasts, By Application

8.4.5.2.1.    Monitoring, Detection and Diagnosis

8.4.5.2.2.    Managing and Treatment

8.4.5.2.3.    Health, Wellness and Prevention

8.4.5.2.4.    Clinical Trials

8.4.6.   Rest of Europe

8.4.6.1.    Rest of Europe Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

8.4.6.1.1.    Clinical Use

8.4.6.1.2.    Non-Clinical Use

8.4.6.2.    Rest of Europe Market Revenue (US$ Mn) and Forecasts, By Application

8.4.6.2.1.    Monitoring, Detection and Diagnosis

8.4.6.2.2.    Managing and Treatment

8.4.6.2.3.    Health, Wellness and Prevention

8.4.6.2.4.    Clinical Trials

8.5.   Key Segment for Channeling Investments

8.5.1.   By Country

8.5.2.   By Product Type

8.5.3.   By Application

9.    Asia Pacific Connected Wearable Patches Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.1.1.   Asia Pacific Market Revenue (US$ Mn)

9.2.   Asia Pacific Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

9.2.1.   Clinical Use

9.2.2.   Non-Clinical Use

9.3.   Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Application

9.3.1.   Monitoring, Detection and Diagnosis

9.3.2.   Managing and Treatment

9.3.3.   Health, Wellness and Prevention

9.3.4.   Clinical Trials

9.4.   Asia Pacific Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Country

9.4.1.   China

9.4.1.1.    China Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

9.4.1.1.1.    Clinical Use

9.4.1.1.2.    Non-Clinical Use

9.4.1.2.    China Market Revenue (US$ Mn) and Forecasts, By Application

9.4.1.2.1.    Monitoring, Detection and Diagnosis

9.4.1.2.2.    Managing and Treatment

9.4.1.2.3.    Health, Wellness and Prevention

9.4.1.2.4.    Clinical Trials

9.4.2.   Japan

9.4.2.1.    Japan Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

9.4.2.1.1.    Clinical Use

9.4.2.1.2.    Non-Clinical Use

9.4.2.2.    Japan Market Revenue (US$ Mn) and Forecasts, By Application

9.4.2.2.1.    Monitoring, Detection and Diagnosis

9.4.2.2.2.    Managing and Treatment

9.4.2.2.3.    Health, Wellness and Prevention

9.4.2.2.4.    Clinical Trials

9.4.3.   India

9.4.3.1.    India Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

9.4.3.1.1.    Clinical Use

9.4.3.1.2.    Non-Clinical Use

9.4.3.2.    India Market Revenue (US$ Mn) and Forecasts, By Application

9.4.3.2.1.    Monitoring, Detection and Diagnosis

9.4.3.2.2.    Managing and Treatment

9.4.3.2.3.    Health, Wellness and Prevention

9.4.3.2.4.    Clinical Trials

9.4.4.   Southeast Asia

9.4.4.1.    Southeast Asia Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

9.4.4.1.1.    Clinical Use

9.4.4.1.2.    Non-Clinical Use

9.4.4.2.    Southeast Asia Market Revenue (US$ Mn) and Forecasts, By Application

9.4.4.2.1.    Monitoring, Detection and Diagnosis

9.4.4.2.2.    Managing and Treatment

9.4.4.2.3.    Health, Wellness and Prevention

9.4.4.2.4.    Clinical Trials

9.4.5.   Rest of Asia Pacific

9.4.5.1.    Rest of Asia Pacific Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

9.4.5.1.1.    Clinical Use

9.4.5.1.2.    Non-Clinical Use

9.4.5.2.    Rest of Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Application

9.4.5.2.1.    Monitoring, Detection and Diagnosis

9.4.5.2.2.    Managing and Treatment

9.4.5.2.3.    Health, Wellness and Prevention

9.4.5.2.4.    Clinical Trials

9.5.   Key Segment for Channeling Investments

9.5.1.   By Country

9.5.2.   By Product Type

9.5.3.   By Application

10. Middle East and Africa Connected Wearable Patches Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. Middle East and Africa Market Revenue (US$ Mn)

10.2. Middle East and Africa Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

10.2.1. Clinical Use

10.2.2. Non-Clinical Use

10.3. Middle East and Africa Revenue (US$ Mn) and Forecasts, By Application

10.3.1. Monitoring, Detection and Diagnosis

10.3.2. Managing and Treatment

10.3.3. Health, Wellness and Prevention

10.3.4. Clinical Trials

10.4. Middle East and Africa Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Country

10.4.1. GCC Countries

10.4.1.1.  GCC Market Revenue (US$ Mn) and Forecasts, By Product Type

10.4.1.1.1.  Clinical Use

10.4.1.1.2.  Non-Clinical Use

10.4.1.2.  GCC Countries Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Application

10.4.1.2.1.  Monitoring, Detection and Diagnosis

10.4.1.2.2.  Managing and Treatment

10.4.1.2.3.  Health, Wellness and Prevention

10.4.1.2.4.  Clinical Trials

10.4.2. Southern Africa

10.4.2.1.  Southern Africa Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

10.4.2.1.1.  Clinical Use

10.4.2.1.2.  Non-Clinical Use

10.4.2.2.  Southern Africa Market Revenue (US$ Mn) and Forecasts, By Application

10.4.2.2.1.  Monitoring, Detection and Diagnosis

10.4.2.2.2.  Managing and Treatment

10.4.2.2.3.  Health, Wellness and Prevention

10.4.2.2.4.  Clinical Trials

10.4.3. Rest of MEA

10.4.3.1.  Rest of MEA Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

10.4.3.1.1.  Clinical Use

10.4.3.1.2.  Non-Clinical Use

10.4.3.2.  Rest of MEA Market Revenue (US$ Mn) and Forecasts, By Application

10.4.3.2.1.  Monitoring, Detection and Diagnosis

10.4.3.2.2.  Managing and Treatment

10.4.3.2.3.  Health, Wellness and Prevention

10.4.3.2.4.  Clinical Trials

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Product Type

10.5.3. By Application

11. Latin America Connected Wearable Patches Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Latin America Market Revenue (US$ Mn)

11.2. Latin America Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

11.2.1. Clinical Use

11.2.2. Non-Clinical Use

11.3. Latin America Market Revenue (US$ Mn) and Forecasts, By Application

11.3.1. Monitoring, Detection and Diagnosis

11.3.2. Managing and Treatment

11.3.3. Health, Wellness and Prevention

11.3.4. Clinical Trials

11.4. Latin America Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Country

11.4.1. Brazil

11.4.1.1.  Brazil Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

11.4.1.1.1.  Clinical Use

11.4.1.1.2.  Non-Clinical Use

11.4.1.2.  Brazil Market Revenue (US$ Mn) and Forecasts, By Application

11.4.1.2.1.  Monitoring, Detection and Diagnosis

11.4.1.2.2.  Managing and Treatment

11.4.1.2.3.  Health, Wellness and Prevention

11.4.1.2.4.  Clinical Trials

11.4.2. Rest of Latin America

11.4.2.1.  Rest of Latin America Connected Wearable Patches Market Revenue (US$ Mn) and Forecasts, By Product Type

11.4.2.1.1.  Clinical Use

11.4.2.1.2.  Non-Clinical Use

11.4.2.2.  Rest of Latin America Market Revenue (US$ Mn) and Forecasts, By Application

11.4.2.2.1.  Monitoring, Detection and Diagnosis

11.4.2.2.2.  Managing and Treatment

11.4.2.2.3.  Health, Wellness and Prevention

11.4.2.2.4.  Clinical Trials

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Product Type

11.5.3. By Application

12. Competitive Benchmarking

12.1. Player Positioning Analysis

12.2. Global Presence and Growth Strategies

13. Player Profiles

13.1. Abbott Laboratories

13.1.1. Company Details

13.1.2. Company Overview

13.1.3. Product Offerings

13.1.4. Key Developments

13.1.5. Financial Analysis

13.1.6. SWOT Analysis

13.1.7. Business Strategies

13.2. Blue Spark Technologies

13.2.1. Company Details

13.2.2. Company Overview

13.2.3. Product Offerings

13.2.4. Key Developments

13.2.5. Financial Analysis

13.2.6. SWOT Analysis

13.2.7. Business Strategies

13.3. Chrono Therapeutics

13.3.1. Company Details

13.3.2. Company Overview

13.3.3. Product Offerings

13.3.4. Key Developments

13.3.5. Financial Analysis

13.3.6. SWOT Analysis

13.3.7. Business Strategies

13.4. G-Tech Inc.

13.4.1. Company Details

13.4.2. Company Overview

13.4.3. Product Offerings

13.4.4. Key Developments

13.4.5. Financial Analysis

13.4.6. SWOT Analysis

13.4.7. Business Strategies

13.5. iRhythm

13.5.1. Company Details

13.5.2. Company Overview

13.5.3. Product Offerings

13.5.4. Key Developments

13.5.5. Financial Analysis

13.5.6. SWOT Analysis

13.5.7. Business Strategies

13.6. KENZEN, Gentag Inc.

13.6.1. Company Details

13.6.2. Company Overview

13.6.3. Product Offerings

13.6.4. Key Developments

13.6.5. Financial Analysis

13.6.6. SWOT Analysis

13.6.7. Business Strategies

13.7. Medtronic

13.7.1. Company Details

13.7.2. Company Overview

13.7.3. Product Offerings

13.7.4. Key Developments

13.7.5. Financial Analysis

13.7.6. SWOT Analysis

13.7.7. Business Strategies

13.8. NeuroMetrix

13.8.1. Company Details

13.8.2. Company Overview

13.8.3. Product Offerings

13.8.4. Key Developments

13.8.5. Financial Analysis

13.8.6. SWOT Analysis

13.8.7. Business Strategies

13.9. Nemaura Medical Inc.

13.9.1. Company Details

13.9.2. Company Overview

13.9.3. Product Offerings

13.9.4. Key Developments

13.9.5. Financial Analysis

13.9.6. SWOT Analysis

13.9.7. Business Strategies

13.10. Preventice Solutions

13.10.1.  Company Details

13.10.2.  Company Overview

13.10.3.  Product Offerings

13.10.4.  Key Developments

13.10.5.  Financial Analysis

13.10.6.  SWOT Analysis

13.10.7.  Business Strategies

13.11. Proteus Digital Health, Inc.

13.11.1.  Company Details

13.11.2.  Company Overview

13.11.3.  Product Offerings

13.11.4.  Key Developments

13.11.5.  Financial Analysis

13.11.6.  SWOT Analysis

13.11.7.  Business Strategies

13.12. Qardio

13.12.1.  Company Details

13.12.2.  Company Overview

13.12.3.  Product Offerings

13.12.4.  Key Developments

13.12.5.  Financial Analysis

13.12.6.  SWOT Analysis

13.12.7.  Business Strategies

13.13. Qualcomm Inc.

13.13.1.  Company Details

13.13.2.  Company Overview

13.13.3.  Product Offerings

13.13.4.  Key Developments

13.13.5.  Financial Analysis

13.13.6.  SWOT Analysis

13.13.7.  Business Strategies

13.14. Sensium Healthcare

13.14.1.  Company Details

13.14.2.  Company Overview

13.14.3.  Product Offerings

13.14.4.  Key Developments

13.14.5.  Financial Analysis

13.14.6.  SWOT Analysis

13.14.7.  Business Strategies

13.15. TempTraq

13.15.1.  Company Details

13.15.2.  Company Overview

13.15.3.  Product Offerings

13.15.4.  Key Developments

13.15.5.  Financial Analysis

13.15.6.  SWOT Analysis

13.15.7.  Business Strategies

13.16. Vital Connect

13.16.1.  Company Details

13.16.2.  Company Overview

13.16.3.  Product Offerings

13.16.4.  Key Developments

13.16.5.  Financial Analysis

13.16.6.  SWOT Analysis

13.16.7.  Business Strategies

13.17. Vancive Medical

13.17.1.  Company Details

13.17.2.  Company Overview

13.17.3.  Product Offerings

13.17.4.  Key Developments

13.17.5.  Financial Analysis

13.17.6.  SWOT Analysis

13.17.7.  Business Strategies

 

 

 Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

At Absolute Markets Insights, we use both top-down and bottom-up approach for calculating the market estimates and market forecast data. We allocate year-on-year growth rate from 2018 to 2026 and reach to the calculations for the global CAGR. Basically for estimation of the products and applications, usually we follow bottom-up approach, where we track the trends in different regions and their countries. We track down the growth factors, restraints, rules & regulations and opportunities for each country  and its region and finally calculate the global numbers. We first track the growth for the U.S. and Rest of North America. With these factors we can estimate the growth and trend for North America, similar approach would be taken for Europe, Asia Pacific, Latin America and Middle East & Africa. Finally, through our home grown model we reach to estimation and forecasting of the global numbers.   

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends. 

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

 

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 204

    Backtrace:

    File: /home/absolute/public_html/application/views/pages/reportpage.php
    Line: 204
    Function: _error_handler

    File: /home/absolute/public_html/application/controllers/Report.php
    Line: 153
    Function: view

    File: /home/absolute/public_html/index.php
    Line: 315
    Function: require_once